# Sumitomo Pharma America, Inc., Marlborough, MA – FDA Inspections

Source: https://www.keypedia.com/companies/sumitomo-pharma-america-inc/f5f01b1a-a43a-478e-a89c-f2d7c3003136

> Inspection records and compliance data for Sumitomo Pharma America, Inc. in Marlborough, Massachusetts. 9 FDA inspections on record, last inspected August 02, 2024.

---

## Details

- Name: Sumitomo Pharma America, Inc.
- FEI Number: 1222021
- Address Line 1: 84 Waterford Dr
- City: Marlborough
- State: Massachusetts
- Zip Code: 01752
- Country Name: United States
- Address: 84 Waterford Dr, Marlborough, Massachusetts 01752, United States
- Country: United States

## Related Documents

- FDA Inspection 1242239 - Sumitomo Pharma America, Inc. - 2024-08-02 — classification: No Action Indicated (NAI), source: FDA, date: August 2, 2024
- FDA Inspection 1161579 - Sumitomo Pharma America, Inc. - 2021-11-05 — classification: No Action Indicated (NAI), source: FDA, date: November 5, 2021
- [FDA Inspection 915063 - Sumitomo Pharma America, Inc. - 2015-01-23](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/d108866d-e164-4636-94bd-c5c66405a7b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 23, 2015
- [FDA Inspection 843011 - Sumitomo Pharma America, Inc. - 2013-05-24](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/c12582b5-74d3-4a7d-a421-e9392e6a3fe4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2013
- [FDA Inspection 759431 - Sumitomo Pharma America, Inc. - 2011-12-09](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/7c1c1c35-c67a-4bf4-a6af-768c1a312d45) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2011
- FDA Inspection 723394 - Sumitomo Pharma America, Inc. - 2011-04-20 — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2011
- FDA Inspection 723394 - Sumitomo Pharma America, Inc. - 2011-04-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2011
- [FDA Inspection 668170 - Sumitomo Pharma America, Inc. - 2010-06-03](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/be9e2598-104d-44ae-b3c7-1b9e6e6cd3d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 3, 2010
- FDA Inspection 621672 - Sumitomo Pharma America, Inc. - 2009-10-20 — classification: No Action Indicated (NAI), source: FDA, date: October 20, 2009
- [FDA Inspection 608872 - Sumitomo Pharma America, Inc. - 2009-09-01](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/bf1aa7f0-a205-4cab-af6d-6d2c250315a8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 1, 2009

## Related Companies

- [Boston Home Infusion Inc.](https://www.keypedia.com/companies/boston-home-infusion-inc/856c4b87-887b-4e84-95e8-f796620b190d)
- [Life Supply Corp.](https://www.keypedia.com/companies/life-supply-corp/0fd8af72-2a6a-4db3-a062-6a0b657cdd44)
- [Takeda Pharmaceuticals USA](https://www.keypedia.com/companies/takeda-pharmaceuticals-usa/2cc60460-dde7-47a7-968e-c06ce6a85515)
- [AstraZeneca LP](https://www.keypedia.com/companies/astrazeneca-lp/aed77fd7-665b-4d39-96b1-13c588ef3a24)
- [Alyssa R. Kratochvil, D.O.](https://www.keypedia.com/companies/alyssa-r-kratochvil-do/8481f76f-2c09-4cc3-8150-53d9ad611502)
- [Airgas USA, LLC](https://www.keypedia.com/companies/airgas-usa-llc/dd979ffc-ad5b-4251-be11-3346b7718e11)
- [Spaulding Rehabilitation Hospital IRB](https://www.keypedia.com/companies/spaulding-rehabilitation-hospital-irb/86137986-b83b-4567-b289-b86799414681)
- [Egilius L.H. Spierings, MD, PhD](https://www.keypedia.com/companies/egilius-lh-spierings-md-phd/359bc01f-723b-4bd8-9883-d96f690d54a1)
- [Mangiacotti, Inc.](https://www.keypedia.com/companies/mangiacotti-inc/f6ae3ca7-7cf6-42b4-8ce8-92bec92bd06f)
- [Paul Gerard Guy Richardson, M.D.](https://www.keypedia.com/companies/paul-gerard-guy-richardson-md/89b4d5a4-f799-446b-a22d-3009e3743bc6)